Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(55)
•••
Comment by frohlir944on Mar 03, 2018 8:12pm
134 Views
Post# 27657134

RE:RE:RE:RE:RE:RE:RE:RE:almost like

RE:RE:RE:RE:RE:RE:RE:RE:almost likeI angry at myself for letting you pull me into the gutter.  I try to be a positive influence to everyone around me wether that be family, friends, or coworkers.  ( if I had to guess about something, you probably drag everyone down in every aspect of your life and not just here)

I have not been part of any private placements, nor am I going to be part of the next one.

All of your guesses on everything have always been wrong!

My answer to what a small private placement is the minimum dollar amount that gets us past a nasdaq listing and to the point where upfront milestones and collaborations are paid for by The pharmaceutical  partners.

Please offer an alternative.  ( you are always complaining that life is not fair to you,  what would you consider a viable alternative for a junior stock company that is sitting on this technology, with this talent and needs to translate that into the end goal that everyone wants)

Your anger at the situation and you feeling  sorry for yourself doesn't help in any way

Please find something that will bring you peace, hobby, church, something.

Surprise us all and contribute something positive. 

Give us an alternative ( pretend you are CEO and need to move this forward, what would you do.)


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities